Abstract:We report two novel intronic variants of FBN1 (c.6163+1484A>T and c.5788+36C>A) associated with Marfan syndrome in two unrelated families. Reverse transcription‐PCR and targeted sequencing revealed retention of in‐frame or out‐of‐frame intronic sequences in the FBN1 transcript. This study points out the importance of intronic sequence analysis and the need for integrative functional studies in Marfan syndrome diagnosis. Background Marfan syndrome (MFS), caused by pathogenic variants of FBN1 (fibrillin‐1), is a systemic connective tissue disorder with variable phenotypes and treatment responsiveness depending on the variant. However, a significant number of individuals with MFS remain genetically unexplained. In this study, we report novel pathogenic intronic variants in FBN1 in two unrelated families with MFS. Methods We evaluated subjects with suspected MFS from two unrelated families using Sanger sequencing or multiplex ligation‐dependent probe amplification of FBN1 and/or panel‐based next‐generation sequencing. As no pathogenic variants were identified, whole‐genome sequencing was performed. Identified variants were analyzed by reverse transcription‐PCR and targeted sequencing of FBN1 mRNA harvested from peripheral blood or skin fibroblasts obtained from affected probands. Results We found causative deep intronic variants, c.6163+1484A>T and c.5788+36C>A, in FBN1. The splicing analysis revealed an insertion of in‐frame or out‐of‐frame intronic sequences of the FBN1 transcript predicted to alter function of calcium‐binding epidermal growth factor protein domain. Family members carrying c.6163+1484A>T had high systemic scores including prominent skeletal features and aortic dissection with lesser aortic dilatation. Family members carrying c.5788+36C>A had more severe aortic root dilatation without aortic dissection. Both families had ectopia lentis. Conclusion Variable penetrance of the phenotype and negative genetic testing in MFS families should raise the possibility of deep intronic FBN1 variants and the need for additional molecular studies. This study expands the mutation spectrum of FBN1 and points out the importance of intronic sequence analysis and the need for integrative functional studies in MFS diagnosis.

The role of genetic testing in Marfan syndrome

Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations

Exon 47 Skipping of Fibrillin-1 Leads Preferentially to Cardiovascular Defects in Patients with Thoracic Aortic Aneurysms and Dissections

Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies

Marfan syndrome and aortic involvement: a narrative review

Genotype-Phenotype Correlations of Marfan Syndrome and Related Fibrillinopathies: Phenomenon and Molecular Relevance

Association of modifiers and other genetic factors explain Marfan syndrome clinical variability

Management of aortic disease in children with FBN1 -related Marfan syndrome

Marfan and Loeys-Dietz aortic phenotype: A potential tool for diagnosis and management

Marfan Syndrome: Whole-Exome Sequencing Reveals De Novo Mutations, Second Gene and Genotype–phenotype Correlations in the Chinese Population

Reclassification of an FBN1 variant emphasizes the importance of segregation analysis, information sharing, and multidisciplinary teamwork in understanding genetic variants in health and disease

Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing

Increased Frequency of FBN1 Frameshift and Nonsense Mutations in Marfan Syndrome Patients with Aortic Dissection

Diagnosis of Marfan Syndrome Following Progressive Myopia and Secondary Lens-Induced Angle Closure Crisis

Marfan Syndrome: new diagnostic criteria, same anesthesia care? Case report and review

A Marfan syndrome gene expression phenotype in cultured skin fibroblasts

Neonatal Marfan syndrome: a case report of a novel fibrillin 1 mutation, with genotype-phenotype correlation and brief review of the literature

Identification of gross deletions in FBN1 gene by MLPA

Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome

Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan Patients

Two novel mutations of fibrillin-1 gene correlate with different phenotypes of Marfan syndrome in Chinese families.